RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. Its products include Sterile Liquid Dose products that consist of generic ophthalmic products in unit and multi-dose presentations, sterile unit dose inhalation respiratory products, and injectable drugs. The company, through its subsidiaries, also manufactures active pharmaceutical ingredients for pharmaceutical companies in the United States, Europe, and Asia. Its customers include hospitals and hospital group purchasing organizations, national and regional wholesalers, direct retail pharmacy stocking chains, homecare companies, and outpatient surgery centers and ambulatory care clinics. The company has partnership agreements with Stason Pharmaceuticals, Inc.; Alkem Laboratories Limited; and Zach Systems S.p.A. RxElite is headquartered in Meridian, Idaho. RxElite, Inc. was formerly a subsidiary of Piramal Enterprises Limited.
Frequently asked questions
What sector does RxElite Inc (RXEI) operate in?
RxElite Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is RxElite Inc (RXEI) current stock price?
As of the latest data, RxElite Inc stock price is $0.00, with a previous close of $0.00.
What is RxElite Inc (RXEI) Earnings Per Share (EPS)?
The trailing EPS is -$0.03.
Does RxElite Inc (RXEI) pay dividends?
No. RxElite Inc does not pay a dividend.
What is RxElite Inc (RXEI) beta (volatility) score?
RxElite Inc has a beta of -33.302, indicating lower volatility than the overall market.